Pierconti et al. found that PD-L1 expression in tumor cells and in immune cells was higher in BCG-unresponsive bladder cancer patients than in BCG-responders, suggesting BCG itself could enhance PD-1 and PD-L1 [23]. This evidence concerns the gene PDCD1 and neoplasm.